Clinical Trials on Minor Head Injury in Liechtenstein
Total 0 results
Nothing found
Sponsors and Collaborators
- Clinic of the International Institute of Postgraduate Education Ministry of Healthcare of the Republic of Kazakhstan
- Dr. Khaled Ahmed Yassen
- Jinxiang County People's Hospital
- Hospital Santos Reyes de Aranda de Duero, Burgos
- Diabetes Research Institute, Munich, Germany.
- kıvan çevik kaya
- South Texas Health System McAllen
- Retina Foundation of Canada
- Pearl Network
- Canadian Glycomics Network (GlycoNet)
- Phoenix VA Health Care System
- EXCELYA Bordeaux
- Alcohol Education and rehabilitation Fund
- Merve Şeker
- Rivus Pharmaceuticals, Inc.
- Critical Care Pharmacotherapy Trials Network
- EndoTheia
- Department of Orthopedics, Norrköping
- Orthopädisch-Unfallchirurgische Praxis Dr Lembeck & Dr Pampel
- Bettina Eiger
- View Full List
Medical Conditions
- 1- Primary (Sarcomeric) Hypertrophic Cardiomyopathy
- Fluorescein Angiography
- Presence / Absence of EBV
- Poststroke Fatigue
- Dystonic Disorders
- Racial Bias
- Secondary Pulmonary Arterial Hypertension
- Organic Anion Transporting Polypeptide1B1 (OATP1B1)
- Newborn Infants
- Tumor Cell, Circulating
- Malignant Pelvic Neoplasm
- Encephalitis, Arbovirus
- Myocardial Haemorrhage
- Myocardial Infarction (MI) or Acute Myocardial Infarction (AMI)
- Cystic Renal Disease
- Acute Rotator Cuff Tear Related to Trauma
- Morton's Neuroma
- Ruptured Achilles Tendon
- Deep Neck Space Infections
- Acute Upper Gastrointestinal Non Variceal Hemorrhage
- View Full List
Drug Interventions
- Nicoderm C-Q Transdermal Product
- Visanne (Dienogest, BAY86-5258)
- Cetuximab
- Tenofovir
- Ketamine 0.3 mg/kg at anesthesia induction
- Sipuleucel-T
- Vinorelbine tartrate
- 6-Mercaptopurine
- Anastrozole
- Tranexamic acid
- Trastuzumab in combination with SubQ GM-CSF
- Follitropin beta liquid formulation
- 5.0g SRT501
- PCO371
- Percutaneous sirolimus
- Amisulpride Oral Tablet
- Granulocyte colony-stimulating factor
- Sodium Nitroprusside
- Modified Bolus 5-FU/LV with Irinotecan
- 30 mg CVL-231 as slow-release MR formulation
- View Full List
CROs by country
- Contract Research Organizations in Austria
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Colombia
- Contract Research Organizations in El Salvador
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Singapore
- Contract Research Organizations in Venezuela
- CRO list by country